JMV1155: A novel inhibitor of glycine-extended progastrin-mediated growth of a human colon cancer in vivo

Keyphrases

• Tumor 100%
• Progastrin 100%
• Human Colon Cancer 100%
• Novel Inhibitors 100%
• Glycine 100%
• Mediated Growth 100%
• Gastrin-releasing Peptide Receptor Antagonist 66%
• Protein Content 66%
• DNA Content 66%
• DLD-1 66%
• Gastrointestinal Cancer 33%
• Colon Adenocarcinoma 33%
• Gastrin 33%
• Days of Treatment 33%
• Tumor Size 33%
• Saline Control 33%
• Tumor Weight 33%
• Athymic nude Mice 33%
• DLD-1 Cells 33%
• Induced Growth 33%
• Biosynthetic Precursor 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Progastrin 100%
• Colon Carcinoma 100%
• Cholecystokinin B Receptor Antagonist 40%
• Gastrin 20%
• Nude Mouse 20%
• Digestive System Cancer 20%

Immunology and Microbiology

• Colon 100%
• DNA Content 50%
• Protein Content 50%
• Precursor 25%
• Nude Mouse 25%
• Tumor Volume 25%